Breaking Into a Saturated Relapsing Remitting Multiple Sclerosis Market: Where Should Developers Focus?
01. August 2023 12:02 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Despite outward appearances of being a stagnant market, the relapsing remitting multiple sclerosis (RMS) market continues to offer drug...
TG THERAPEUTICS, INC. (NASDAQ: TGTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against TG Therapeutics, Inc. (NASDAQ: TGTX)
13. September 2022 01:45 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in TG Therapeutics? If so, please visit TG Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Missfresh, Molecular Partners, TG Therapeutics, and 17EdTech and Encourages Investors to Contact the Firm
11. September 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
TGTX DEADLINE ALERT: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action – TGTX
10. September 2022 14:00 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between January...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Molecular Partners, TG Therapeutics, 17EdTech, and Enochian and Encourages Investors to Contact the Firm
06. September 2022 21:26 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
TG THERAPEUTICS, INC. (NASDAQ: TGTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against TG Therapeutics, Inc. (NASDAQ: TGTX)
06. September 2022 16:00 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in TG Therapeutics? If so, please visit TG Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Loses to Secure Counsel Before Important September 16 Deadline in Securities Class Action – TGTX
03. September 2022 10:16 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 03, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Molecular Partners, TG Therapeutics, 17EdTech, and Enochian and Encourages Investors to Contact the Firm
31. August 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
TG THERAPEUTICS, INC. (NASDAQ: TGTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against TG Therapeutics, Inc. (NASDAQ: TGTX)
30. August 2022 12:00 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in TG Therapeutics? If so, please visit TG Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to...
TGTX Shareholder Alert: Robbins LLP Urges Investors With Significant Losses in TG Therapeutics, Inc. (TGTX) to Inquire About Becoming Lead Plaintiff
29. August 2022 13:40 ET
|
Robbins LLP
SAN DIEGO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The Class: Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons who purchased or...